The multifactorial etiology of graft-versus-host disease
- 31 December 1987
- journal article
- Published by Elsevier BV in Immunology Today
- Vol. 8 (7-8), 209-212
- https://doi.org/10.1016/0167-5699(87)90166-6
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- MARROW TRANSPLANTATION FOR THALASSAEMIA FOLLOWING BUSULPHAN AND CYCLOPHOSPHAMIDEThe Lancet, 1985
- ELIMINATION OF GRAFT-VERSUS-HOST DISEASE BY IN-VITRO DEPLETION OF ALLOREACTIVE LYMPHOCYTES WITH A MONOCLONAL RAT ANTI-HUMAN LYMPHOCYTE ANTIBODY (CAMPATH-1)The Lancet, 1984
- Predictive factors for acute graft-versus-host disease in patients transplanted with HLA-identical bone marrowBlood, 1984
- DEPLETION OF T LYMPHOCYTES IN DONOR MARROW PREVENTS SIGNIFICANT GRAFT-VERSUS-HOST DISEASE IN MATCHED ALLOGENEIC LEUKAEMIC MARROW TRANSPLANT RECIPIENTSThe Lancet, 1984
- Lethal GVHD Across Minor Histocompatibility Barriers: Nature of the Effector Cells and Role of the H-2 ComplexImmunological Reviews, 1983
- Graft-versus-Host Disease and Survival in Patients with Aplastic Anemia Treated by Marrow Grafts from HLA-Identical SiblingsThe New England Journal of Medicine, 1983
- PRETREATMENT OF DONOR BONE MARROW WITH MONOCLONAL ANTIBODY OKT3 FOR PREVENTION OF ACUTE GRAFT-VERSUS-HOST DISEASE IN ALLOGENEIC HISTOCOMPATIBLE BONE-MARROW TRANSPLANTATIONThe Lancet, 1982
- THYMUS TRANSPLANTATION AFTER ALLOGENEIC BONE MARROW GRAFT TO PREVENT CHRONIC GRAFT-VERSUS-HOST DISEASE IN HUMANSTransplantation, 1982
- Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow.The Journal of Experimental Medicine, 1978
- Treatment of aplastic anemia by marrow transplantation from HLA identical siblings. Prognostic factors associated with graft versus host disease and survival.JCI Insight, 1977